Liver Diseases  >>  Avastin (bevacizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Avastin (bevacizumab) / Roche
NCT00142467: Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Completed
2
33
US
Gemcitabine, Gemzar, Oxaliplatin, Eloxatin, Bevacizumab, Avastin
Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Genentech, Inc., Sanofi-Synthelabo, Eli Lilly and Company
Hepatocellular Carcinoma
08/06
06/11
NCT00106054: Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

Terminated
2
2
US
Combination therapy of irinotecan with 5-FU, leucovorin plus bevacizumab in the neoadjuvant setting.
Pfizer
Colorectal Neoplasms, Liver Neoplasms
09/06
09/06
NCT02013830: A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Completed
2
45
RoW
bevacizumab [Avastin], capecitabine [Xeloda]
Hoffmann-La Roche
Liver Cancer
03/08
03/08
NCT00508872: Folfox-B Study for Patients With Colorectal Liver Metastases

Terminated
2
2
US
5-Fluorouracil, 5-FU, Adrucil, Efudex, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAb-VEGF, Leucovorin, Citrovorum, Wellcovorin, Oxaliplatin, Eloxatin
M.D. Anderson Cancer Center, Sanofi
Colorectal Liver Metastases
06/09
06/09
NCT00605722: A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Completed
2
51
RoW
bevacizumab (Avastin), erlotinib (Tarceva)
Hoffmann-La Roche
Liver Cancer
09/10
09/10
NCT00775073 / 2007-005422-76: Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Checkmark P2 data-ILCA
Sep 2012 - Sep 2012: P2 data-ILCA
Checkmark P2 data-ASCO
Jun 2012 - Jun 2012: P2 data-ASCO
Checkmark Data-DDW
More
Completed
2
33
Europe
Everolimus, Bevacizumab, RAD001, Avastin
Gerhard Treiber, Crolll Gmbh, Estimate, GmbH, Janssen Diagnostics, LLC
Hepatocellular Carcinoma
01/11
04/12
NCT00576199: A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer

Completed
2
30
RoW
Bevacizumab, Avastin, Transarterial chemoembolisation (TACE)
Hoffmann-La Roche
Liver Cancer
05/11
05/11
BOS2, NCT01508000 / 2010-019238-29: Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

Checkmark For wild-type RAS mutant 1st-line mCRC
Jun 2013 - Jun 2013: For wild-type RAS mutant 1st-line mCRC
Terminated
2
44
Europe
FOLFOX6, Chemotherapy, Bevacizumab, Avastin, Panitumumab, Vectibix, Surgery
European Organisation for Research and Treatment of Cancer - EORTC, Amgen, Roche Pharma AG
Colorectal Cancer Metastatic, Liver Metastases, KRAS Wild Type Colorectal Cancer
09/16
09/16

Download Options